v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues $ 371,070 $ 377,427 $ 1,059,433 $ 1,051,069
Cost of goods sold 285,847 302,706 817,857 843,853
Gross profit 85,223 74,721 241,576 207,216
Selling, general, and administrative expenses 60,160 58,367 178,194 165,277
Operating income 25,063 16,354 63,382 41,939
Other expenses (income):        
Interest expense 177 160 485 502
Other expense (income), net (1,091) (437) (11,165) (887)
Total other expenses (income) (914) (277) (10,680) (385)
Income before income taxes 25,977 16,631 74,062 42,324
Provision for income taxes 6,857 7,038 19,277 14,631
Net income 19,120 9,593 54,785 27,693
Less net income (loss) attributable to non-controlling interests 440 (225) 938 (603)
Net income attributable to Guardian Pharmacy Services, Inc. $ 18,680 $ 9,818 $ 53,847 $ 28,296
Net income per share of Class A and Class B common stock        
Basic (in usd per share) [1] $ 0.29 $ 0.16 $ 0.85 $ 0.46
Diluted (in usd per share) [1] $ 0.29 $ 0.15 $ 0.84 $ 0.45
Weighted-average Class A and Class B common shares outstanding        
Basic (in shares) 63,343 62,124 63,330 62,071
Diluted (in shares) 63,916 63,432 63,813 63,180
[1] See Note 7 - Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share.